Cor Vasa 2026, 68(5):555-561 | DOI: 10.33678/cor.2026.072

Impact of COVID-19 Pandemic on In-hospital and Long-term Outcomes of ST Elevation Myocardial Infarction

Azza Abdel Moniem Farraga, Ahmed Adel Mohamed Elamragya, Sameh Mohamed Helmy Elkaffasa, Dalia Rifaat Elremisya, Wafaa Hamed Omar Khalifab
a Cardiology Department, Faculty of Medicine, Cairo University, Cairo, Egypt
b Cardiology Department, Student´s Hospital, Cairo University, Cairo, Egypt

Background: The COVID-19 pandemic significantly impacted cardiovascular outcomes worldwide. This study evaluated the impact of the COVID-19 pandemic on in-hospital and long-term (1-year) outcomes in patients with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PPCI).

Methods: This retrospective observational study included 317 STEMI patients treated with PPCI between March 1, 2019, and February 28, 2022. Patients were categorized into group A (pre-pandemic, n = 107), group B1 (during pandemic, non-COVID-19, n = 169), and group B2 (during pandemic, confirmed COVID-19, n = 41). Clinical characteristics, in-hospital post-PCI complications, hospital stay duration, and 1-year follow -up outcomes (readmission for chest pain and mortality) were analyzed.

Results: Heart failure was the most common in-hospital post-PCI complication, occurring significantly more in COVID-19 patients (group B2) compared to pre-pandemic patients (48.8% vs. 24.3%, p = 0.004). Group B2 patients also experienced higher rates of cardiogenic shock (29.3% vs. 6.5%, p <0.001), contrast-induced nephropathy (22.0% vs. 8.4%, p = 0.024), and significantly longer hospital stays (9.27 ± 5.30 vs. 4.20 ± 3.26 days, p <0.001). Conversely, non-COVID-19 patients during the pandemic had shorter hospital stays (3.14 ± 2.40 days, p = 0.004). At the 1-year follow-up, hospital readmission for chest pain was more frequent before the pandemic, whereas 1-year mortality rates remained comparable across all groups.

Conclusion: STEMI patients with concomitant COVID-19 infection undergoing PPCI face higher risks of in -hospital post-PCI complications and prolonged hospitalization, though 1-year mortality rates remain comparable to pre-pandemic.

Keywords: Acute coronary syndrome, COVID-19, ST-elevation myocardial infarction

Received: December 16, 2025; Revised: August 3, 2026; Accepted: August 8, 2026; Prepublished online: October 9, 2026; Published: October 20, 2026  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Farrag AAM, Elamragy AAM, Elkaffas SMH, Elremisy DR, Khalifa WHO. Impact of COVID-19 Pandemic on In-hospital and Long-term Outcomes of ST Elevation Myocardial Infarction. Cor Vasa. 2026;68(5):555-561. doi: 10.33678/cor.2026.072.
Download citation

References

  1. Zhou Y, Ji S. Experimental and numerical study on the transport of droplet aerosols generated by occupants in a fever clinic. Build Environ 2021;187:107402. Go to original source... Go to PubMed...
  2. Wu F, Zhao S, Yu B, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579:265-269. Go to original source... Go to PubMed...
  3. Sohrabi C, Alsafi Z, O'Neill N, et al. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). Int J Surg 2020;76:71-76. Go to original source...
  4. Bansal M. Cardiovascular disease and COVID-19. Diabetes Metab Syndr 2020;14:247-250. Go to original source... Go to PubMed...
  5. Nishiga M, Wang DW, Han Y, et al. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat Rev Cardiol 2020;17:543-558. Go to original source...
  6. Momtazmanesh S, Shobeiri P, Hanaei S, et al. Cardiovascular disease in COVID-19: a systematic review and meta-analysis of 10,898 patients and proposal of a triage risk stratification tool. Egypt Heart J 2020;72(1). Go to original source...
  7. Mesquita D, Carmo P, Cabanelas N, et al. Cardiac arrhythmias in patients presenting with COVID 19 treated in Portuguese hospitals: A national registry from the Portuguese Association of Arrhythmology, Rev Port Cardiol (Engl Ed) 2021;40:573-580. Go to original source... Go to PubMed...
  8. Reinstadler SJ, Reindl M, Lechner I, et al. Effect of the COVID-19 pandemic on treatment delays in patients with stsegment elevation myocardial infarction. J Clin Med 2020;9:1- 10. Go to original source...
  9. Furnica C, Chistol RO, Chiran DA, et al. The Impact of the Early COVID-19 Pandemic on ST Segment Elevation Myocardial Infarction Presentation and Outcomes - A Systematic Review and Meta-Analysis. Diagnostics. 2022;12:588. Go to original source... Go to PubMed...
  10. Ibanez B, James S, Agewall S et al. ESC Scientific Document Gr. Eur Heart. Published online 201AD.
  11. Appleby MA, Michaels AD, Chen M, Michael CG. Importance of the TIMI frame count: implications for future trials. Curr Control Trials Cardiovasc Med 2000;1:31-34. Go to original source...
  12. Ayad S, Shenouda R, Henein M. The impact of covid-19 on in-hospital outcomes of st-segment elevation myocardial infarction patients. J Clin Med 2021;10:1-7. Go to original source...
  13. Little CD, Kotecha T, Candilio L, et al. COVID-19 pandemic and STEMI: pathway activation and outcomes from the pan-London heart attack group. Open Heart 2020;7:e001432. Go to original source...
  14. Coughlan JJ, Chongprasertpon N, Arockiam S, et al. COVID-19 and STEMI: A snapshot analysis of presentation patterns during a pandemic. IJC Heart and Vasculature 2020;30:4-6. Go to original source... Go to PubMed...
  15. Kwok CS, Gale CP, Kinnaird T, et al. Impact of COVID-19 on percutaneous coronary intervention for ST-elevation myocardial infarction. Heart 2020;106:1805-1811. Go to original source... Go to PubMed...
  16. Erol MK, Kayikçioğlu M, Kiliçkap M, et al. Treatment delays and in-hospital outcomes in acute myocardial infarction during the COVID-19 pandemic: A nationwide study. Anatol J Cardiol 2020;24:334-342. Go to original source...
  17. Gong X, Zhou L, Dong T, et al. American Journal of Emergency Medicine Impact of COVID-19 pandemic on STEMI undergoing primary PCI treatment in Beijing, China. Am J Emerg Med 2022;53:68-72. Go to original source... Go to PubMed...
  18. Kiris T, Avci E, Ekin T, et al. Impact of COVID - 19 outbreak on patients with ST - segment elevation myocardial infarction (STEMI) in Turkey : results from TURSER study (TURKISH St- segment elevation myocardial infarction registry). J Thromb Thrombolysis 2022;53:321-334. Go to original source... Go to PubMed...
  19. Tam CF, Cheung KS, Lam S, et al. Impact of Coronavirus Disease 2019 (COVID 19) Outbreak on ST-Segment-Elevation Myocardial Infarction Care in Hong Kong, China. Circ Cardiovasc Qual Outcomes 2020;13:e006631. Go to original source...

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.